Now showing items 1-2 of 2

    • Exploring an oncolytic virus triggered PD-L1 response via immunoPET 

      Kramer-Marek G; Hoebart, J; Kramer-Marek, G (Institute of Cancer Research (University Of London), 2023-01-23)
      Oncolytic virotherapy (OV) exploits viruses which preferentially infect and kill cancerous cells. Moreover, oncolytic viruses stimulate the tumour-immune microenvironment towards an inflammatory phenotype. Therefore, OV ...
    • Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy. 

      Mączyńska, J; Raes, F; Da Pieve, C; Turnock, S; Boult, JKR; et al. (BMC, 2022-01-21)
      BACKGROUND: Surgical resection followed by chemo-radiation postpones glioblastoma (GBM) progression and extends patient survival, but these tumours eventually recur. Multimodal treatment plans combining intraoperative ...